VACC - Arbutus ends development of COVID hepatitis b candidates
2023-09-11 17:32:50 ET
More on Arbutus Biopharma
- Arbutus Biopharma appoints Karen Sims as chief medical officer
- Seeking Alpha’s Quant Rating on Arbutus Biopharma
- Historical earnings data for Arbutus Biopharma
- Financial information for Arbutus Biopharma
For further details see:
Arbutus ends development of COVID, hepatitis b candidates